Transgenomic Expects New Cold-PCR License to Extend Mutation-Detection Kit Sensitivity
March 17, 2011
Transgenomic Expects New Cold-PCR License to Extend Mutation-Detection Kit Sensitivity
An expanded license with Dana-Farber Cancer Institute for an offshoot of its Cold-PCR technology allows Transgenomic to develop kits that can detect mutations in common cancer-related genes such as KRAS and P53 directly from blood samples and then analyze the variants using multiple sequencing approaches.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Transgenomic Expands License from Dana Farber to Include Ice COLD-PCR
March 14, 2011 / GenomeWeb Daily News - Transgenomic Using STTR Grant to Explore Ice-Cold-PCR Detection of Pancreatic Cancer Mutations
August 16, 2012 / PCR Insider - Dana-Farber Team Developing High-Throughput Cold-PCR for NGS-Based Mutation Analysis
September 29, 2011 / PCR Insider - Transgenomic Launches NGS-Based Mitochondrial Disease Test, Developing Autism Risk Test
June 21, 2011 / Clinical Sequencing News - Transgenomic Posts 22 Percent Decline in PGx Business, but Predicts Segment 'Swell' in Coming Months
May 18, 2011 / Pharmacogenomics Reporter